low glutathione levels parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors and Beyond Parkinson's disease-specific α-Synuclein variants potentially
Description
doi: 10.5483/BMBRep.2014.47.1.284
High-cost drugs particularly biologics, chemotherapy agents, and specialty infusions frequently require prior authorization before the payer will approve reimbursement
TIP3P water molecules 49 were added to the simulation box (final dimensions 126 x 126 x 186 ) using the VMD Solvate plugin 1.5 (VMD Solvate plugin, Version 1.5
[PubMed] [Google Scholar] 79.Ilic S., Drmic D., Franjic S., Kolenc D., Coric M., Brcic L., Klicek R., Radic B., Sever M., Djuzel V., et al
